$1.25 stock on next positive SAS results (de-risks clinical trial further), $2-$2.50 on Phase II trial success, $5-10 on licensing deal. On the flipside, cash backing of $0.05 on Phase II failure.
Downside only limited to what I'm willing to lose, upside will pay for a nice little vacation home. I'll take those odds any day. Not taking a single share out of my holdings until the outcome is final. Will be a fruitful ride (I hope). All IMO.
FA bagger potential, page-51
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $180.4K | 746.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 79748 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 22818 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |